Overview R-CHOP + GM-CSF for Previously Untreated LCL in Elderly Status: Completed Trial end date: 2010-11-01 Target enrollment: Participant gender: Summary Patients will receive 6 to 8 cycles of R-CHOP (Rituximab, Cyclophosphamide, doxorubicin, vincristine, and prednisone), with GM-CSF. Phase: Phase 2 Details Lead Sponsor: University of Wisconsin, Madison